Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 10
2004 10
2005 11
2006 11
2007 10
2008 16
2009 18
2010 18
2011 12
2012 13
2013 7
2014 17
2015 9
2016 16
2017 17
2018 19
2019 13
2020 28
2021 33
2022 25
2023 20
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

308 results

Results by year

Filters applied: . Clear all
Page 1
Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study.
Tuninetti V, Virano E, Salutari V, Ricotti A, Pisano C, Ducceschi M, Turitto G, Scandurra G, Petrella MC, Forestieri V, Rizzetto M, Mammoliti S, Artioli G, Cioffi R, Borsotti L, Bellero M, Rognone C, Carbone V, Ferrandina G, Mantiero M, Azzolina C, Geninatti E, Pignata S, Valabrega G. Tuninetti V, et al. Among authors: ferrandina g. Eur J Cancer. 2024 May;203:114039. doi: 10.1016/j.ejca.2024.114039. Epub 2024 Mar 30. Eur J Cancer. 2024. PMID: 38598922
Is PET Radiomics Useful to Predict Pathologic Tumor Response and Prognosis in Locally Advanced Cervical Cancer?
Collarino A, Feudo V, Pasciuto T, Florit A, Pfaehler E, de Summa M, Bizzarri N, Annunziata S, Zannoni GF, de Geus-Oei LF, Ferrandina G, Gambacorta MA, Scambia G, Boellaard R, Sala E, Rufini V, van Velden FH. Collarino A, et al. Among authors: ferrandina g. J Nucl Med. 2024 Mar 28:jnumed.123.267044. doi: 10.2967/jnumed.123.267044. Online ahead of print. J Nucl Med. 2024. PMID: 38548352
Survival associated with the use of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node metastasis in cervical cancer.
Bizzarri N, Fedele C, Teodorico E, Certelli C, Pedone Anchora L, Carbone V, Giannarelli D, Fagotti A, Zannoni GF, Valente M, Querleu D, Ferrandina G, Scambia G, Fanfani F. Bizzarri N, et al. Among authors: ferrandina g. Eur J Surg Oncol. 2024 Apr;50(4):108250. doi: 10.1016/j.ejso.2024.108250. Epub 2024 Mar 5. Eur J Surg Oncol. 2024. PMID: 38461568 Free article.
External beam radiotherapy boost versus surgical debulking followed by radiotherapy for the treatment of metastatic lymph nodes in cervical cancer: A systematic review and meta-analysis.
Bizzarri N, Di Berardino S, Benkortbi K, Balaya V, Gambacorta MA, Macchia G, Boulvain M, Feki A, Mathevet P, Lecuru F, Querleu D, Ferrandina G, Scambia G, Guani B. Bizzarri N, et al. Among authors: ferrandina g. Eur J Surg Oncol. 2024 Apr;50(4):108013. doi: 10.1016/j.ejso.2024.108013. Epub 2024 Feb 13. Eur J Surg Oncol. 2024. PMID: 38401353 Free article. Review.
TRImodal DEfinitive invasive vagiNal carcinoma Treatment (TRIDENT protocol): how a standardized approach may change prognostic outcomes.
Lancellotta V, Macchia G, Garganese G, Fionda B, Pezzulla D, De Angeli M, Autorino R, Zinicola T, Gui B, Russo L, Fragomeni SM, Ferrandina G, Rovirosa A, Sala E, Scambia G, Gambacorta MA, Tagliaferri L. Lancellotta V, et al. Among authors: ferrandina g. Int J Gynecol Cancer. 2024 Jan 30:ijgc-2023-004956. doi: 10.1136/ijgc-2023-004956. Online ahead of print. Int J Gynecol Cancer. 2024. PMID: 38290784
Real world data of niraparib in platinum sensitive relapsed ovarian cancer: A multicenter experience of the MITO group.
Musacchio L, Palluzzi E, Di Napoli M, Lauria R, Ferrandina G, Angioli R, Bergamini A, Corrado G, Perniola G, Cassani C, Savarese A, Gori S, Greco F, De Angelis C, Zafarana E, Giannarelli D, Cinieri S, Mosconi AM, Raspagliesi F, Pignata S, Scambia G, Lorusso D. Musacchio L, et al. Among authors: ferrandina g. Gynecol Oncol. 2024 Jan 25;184:24-30. doi: 10.1016/j.ygyno.2024.01.022. Online ahead of print. Gynecol Oncol. 2024. PMID: 38277918
Efficacy of stereotactic body radiotherapy and response prediction using artificial intelligence in oligometastatic gynaecologic cancer.
Macchia G, Cilla S, Pezzulla D, Campitelli M, Laliscia C, Lazzari R, Draghini L, Fodor A, D'Agostino GR, Russo D, Balcet V, Ferioli M, Vicenzi L, Raguso A, Di Cataldo V, Perrucci E, Borghesi S, Ippolito E, Gentile P, De Sanctis V, Titone F, Delle Curti CT, Huscher A, Gambacorta MA, Ferrandina G, Morganti AG, Deodato F. Macchia G, et al. Among authors: ferrandina g. Gynecol Oncol. 2024 Jan 24;184:16-23. doi: 10.1016/j.ygyno.2024.01.023. Online ahead of print. Gynecol Oncol. 2024. PMID: 38271773
Machine-learning prediction of treatment response to stereotactic body radiation therapy in oligometastatic gynecological cancer: A multi-institutional study.
Cilla S, Campitelli M, Antonietta Gambacorta M, Michela Rinaldi R, Deodato F, Pezzulla D, Romano C, Fodor A, Laliscia C, Trippa F, De Sanctis V, Ippolito E, Ferioli M, Titone F, Russo D, Balcet V, Vicenzi L, Di Cataldo V, Raguso A, Giuseppe Morganti A, Ferrandina G, Macchia G. Cilla S, et al. Among authors: ferrandina g. Radiother Oncol. 2024 Feb;191:110072. doi: 10.1016/j.radonc.2023.110072. Epub 2023 Dec 22. Radiother Oncol. 2024. PMID: 38142932
308 results